argenx SE (LON:0QW0)
London · Delayed Price · Currency is GBP · Price in EUR 623.29
+11.82 (1.93%)
At close: Sep 30, 2025
argenx SE Market Cap
argenx SE has a market cap or net worth of 36.18 billion as of October 3, 2025. Its market cap has increased by 49.28% in one year.
Market Cap
36.18B
Enterprise Value
33.30B
Revenue
2.28B
Ranking
n/a
PE Ratio
38.71
Stock Price
623.29
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 97.26M to 36.18B, an increase of 37,099.59%. That is a compound annual growth rate of 69.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 36.18B | 20.79% |
| Dec 31, 2024 | 29.95B | 70.09% |
| Dec 29, 2023 | 17.61B | 3.04% |
| Dec 30, 2022 | 17.09B | 24.91% |
| Dec 31, 2021 | 13.68B | 33.96% |
| Dec 31, 2020 | 10.21B | 96.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.16B |
| GSK plc | 65.55B |
| Haleon | 29.53B |
| Smith & Nephew | 11.62B |
| ConvaTec Group | 4.79B |
| Hikma Pharmaceuticals | 4.09B |
| HUTCHMED (China) | 2.08B |
| Genus | 1.67B |